肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

血清游离轻链升高与慢性淋巴细胞白血病及单克隆B淋巴细胞增多症的关联

Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

原文发布日期:2019-08-05

DOI: 10.1038/s41408-019-0220-x

类型: Article

开放获取: 是

英文摘要:

摘要翻译: 

原文链接:

文章:

血清游离轻链升高与慢性淋巴细胞白血病及单克隆B淋巴细胞增多症的关联

Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

原文发布日期:2019-08-05

DOI: 10.1038/s41408-019-0220-x

类型: Article

开放获取: 是

 

英文摘要:

Chronic lymphocytic leukemia (CLL) and its precursor, monoclonal B-cell lymphocytosis (MBL), are heritable. Serumfree light-chain (sFLC) measures are a prognostic factor for CLL, but their role in susceptibility to CLL is not clear. We investigated differences between sFLC measurements in pre-treatment serum from five groups to inform the association of sFLC with familial and sporadic CLL: (1) familial CLL (n = 154), (2) sporadic CLL (n = 302), (3) familial MBL (n = 87), (4) unaffected first-degree relatives from CLL/MBL families (n = 263), and (5) reference population (n = 15,396). The percent of individuals having elevated monoclonal and polyclonal sFLCs was compared using age-stratified and age- and sex-adjusted logistic regression models. In age groups >50 years, monoclonal sFLC elevations were increased in sporadic and familial CLL cases compared to the reference population (p’s < 0.05). However, there were no statistically significant differences in sFLC monoclonal or polyclonal elevations between familial and sporadic CLL cases (p’s > 0.05). Unaffected relatives and MBL cases from CLL/MBL families, ages >60 years, showed elevated monoclonal sFLC, compared to the reference population (p’s < 0.05). This is the first study to demonstrate monoclonal sFLC elevations in CLL cases compared to controls. Monoclonal sFLC levels may provide additional risk information in relatives of CLL probands.
 

摘要翻译: 

慢性淋巴细胞白血病(CLL)及其前体——单克隆B细胞淋巴细胞增多症(MBL)具有遗传性。血清游离轻链(sFLC)检测是CLL的预后指标,但其在CLL易感性中的作用尚不明确。我们通过分析五组人群治疗前血清的sFLC测量值差异,探讨sFLC与家族性和散发性CLL的关联:(1)家族性CLL(n=154);(2)散发性CLL(n=302);(3)家族性MBL(n=87);(4)CLL/MBL家族中未受累的一级亲属(n=263);(5)参照人群(n=15,396)。采用年龄分层及经年龄、性别调整的逻辑回归模型,比较各组单克隆性与多克隆性sFLC升高者的百分比。在年龄>50岁的人群中,散发性与家族性CLL患者的单克隆sFLC升高比例均显著高于参照人群(P值均<0.05)。但家族性与散发性CLL病例间的单克隆或多克隆sFLC升高无统计学差异(P值均>0.05)。在年龄>60岁的CLL/MBL家族成员中,未受累亲属及MBL患者的单克隆sFLC水平均高于参照人群(P值均<0.05)。本研究首次证实CLL患者存在相较于对照组的单克隆sFLC升高现象。单克隆sFLC水平或可为CLL先证者亲属提供额外的风险信息。

 

原文链接:

Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……